Prestige Consumer Healthcare, Inc. (PBH)
51.78
-0.69
(-1.32%)
USD |
NYSE |
Aug 31, 16:00
51.06
-0.72
(-1.39%)
Pre-Market: 07:22
Prestige Consumer Healthcare Cash from Operations (Annual) : 257.63M for March 31, 2026
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| March 31, 2026 | 257.63M |
| March 31, 2025 | 251.52M |
| March 31, 2024 | 248.93M |
| March 31, 2023 | 229.72M |
| March 31, 2022 | 259.92M |
| March 31, 2021 | 235.61M |
| March 31, 2020 | 217.12M |
| March 31, 2019 | 189.28M |
| March 31, 2018 | 210.11M |
| March 31, 2017 | 147.77M |
| March 31, 2016 | 174.35M |
| March 31, 2015 | 156.26M |
| March 31, 2014 | 111.58M |
| Date | Value |
|---|---|
| March 31, 2013 | 137.60M |
| March 31, 2012 | 67.45M |
| March 31, 2011 | 86.67M |
| March 31, 2010 | 59.43M |
| March 31, 2009 | 66.68M |
| March 31, 2008 | 44.99M |
| March 31, 2007 | 71.90M |
| March 31, 2006 | 53.86M |
| March 31, 2005 | 51.04M |
| March 31, 2004 | 6.137M |
| March 31, 2003 | 12.52M |
| March 31, 2002 | 3.94M |
| March 31, 2001 | 1.978M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Indivior Pharmaceuticals, Inc. | -27.00M |
| ANI Pharmaceuticals, Inc. | 185.22M |
| Corcept Therapeutics, Inc. | 142.00M |
| Veru, Inc. | -30.04M |
| Johnson & Johnson | 24.53B |